DHL said a major new investment will help double revenue for health care logistics by 2030 while FedEx says its technology ...

Logistics giant has laid in billions for expansion and sees big potential in life sciences and e-commerce Read more at The ...

DHL Group plans to spend ... $5 billion in global revenue in 2024. Investment in the health care sector — including medical device, clinical trial, biopharma, cell and gene therapy logistics ...

Facility part of DHL Group’s €500 million investment in Asia Pacific for the life sciences & healthcare infrastructure.

Contract logistics provider DHL Supply Chain has opened an 8,200 sq m Pharma Hub in Singapore. Strategically located near ...

WALTHAM, Mass., April 17, 2025 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a ...

Boehringer Ingelheim and Cue Biopharma (CUE) announced a strategic research collaboration and license agreement to develop and commercialize Cue Biopharma’s CUE-501 product candidate ...

BOSTON, April 14, 2025 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and ...

SINGAPORE - Media OutReach Newswire - 14 April 2025 - DHL Supply Chain, the global leader in contract logistics, launched a new Pharma Hub in Singapore, a dedicated facility for pharmaceutical ...

In a report released today, Michael Aspinall from Jefferies maintained a Buy rating on DHL Group (0H3Q – Research Report), with a price target ...

After mass layoffs, the FDA has started missing certain deadlines, pushing one biopharma to delay a phase ... other major investors like Sofinnova Investments and The Column Group.

The new hub is part of the company’s $568m investment in Asia Pacific for the life sciences and healthcare sector.